glaxosmithkline

Welcome to the 'glaxosmithkline' tag page at Technorati. This page features content from the farthest reaches of the Blogosphere that authors have "tagged" with 'glaxosmithkline'.

Latest blogosphere posts tagged “glaxosmithkline”

• (GSK) GlaxoSmithKline Reports Higher Revenues

  
  Stock Blog Hub — Authority: 461
  GlaxoSmithKline, plc ( GSK ) reported third quarter income of 92 cents per American Depository Share (ADS), 3 cents below the Zacks Consensus Estimate. The company reported earnings of 94 cents in the year-ago period. Third quarter 2009 revenue increased 3%, with growth being driven by strong performances in ...
  19 hours ago

• (GSK) GlaxoSmithKline plc Has Their H1N1 Vaccine Approved

  
  Stock Blog Hub — Authority: 461
  GlaxoSmithKline plc ( GSK ) recently received approval from the U.S. Food and Drug Administration (FDA) for its unadjuvanted influenza A (H1N1) pandemic vaccine.  The FDA approved the supplemental biologics license application (sBLA), which was filed as a strain change supplement to Glaxo’s FluLaval seasonal flu ...
  19 hours ago

• FDA chief defends H1N1 vaccine supply

  
  Survival News Network — Authority: 144
  The head of the U.S. Food and Drug Administration defended the agency’s decision not to use an additive that could have stretched swine flu vaccine supplies, adding that doses should be coming more regularly.The vaccine to prevent the H1N1 strain of influenza has been in short supply following production issues but ...
  1 day ago

• JUST IN: Federal Circuit Denies Vacatur in USPTO Rules Case

  
  IPWatchdog.com | Patents & Patent Law — Authority: 601
  Earlier today the Chief Judge Paul Michel of the United States Court of Appeals for the Federal Circuit issued an Order declaring the pending appeal of Dr. Tafas and GlaxoSmithKline moot due to the fact that USPTO Director David Kappos has withdrawn the rules. The Federal Circuit per Judge Michel, however, denied the ...
  1 day ago

• Suppression of Clinical Trials of Sumatriptan

  
  Health Care Renewal — Authority: 530
  Correspondence to the Lancet two weeks ago revealed another instance in which clinical research studies that failed to provide results favorable to a sponsors product were suppressed. [Tfeft-Hansen  PC. Unpublished clinical trials of sumatriptan. Lancet 2009; 374: 1501-2.  Link here .] Sumatriptan, sold as Imitrex ...
  2 days ago

• Xconomy Videos: Sirtris’ Westphal and Millennium’s Dunsire Talk Cures for Ills of Big Pharma

  
  Xconomy — Authority: 710
  Big Pharma , Life Sciences , ceos Ryan McBride wrote: There’s new a dynamic at work in Big Pharma’s acquisitions of biotech companies in Boston and elsewhere. Drug companies don’t only want to buy biotech firms to enhance their R&D pipelines, they want to bring the innovators behind the biotechs ...
  2 days ago

• Treximet – head off

  
  AdPharm Blog — Authority: 146
  93" height="125" /> Click on image for original file provided by AdPharm “My migraines are so excruciating I just want to take my head off.” Treximet is superior to the ingredient in Imitrex tablets at relieving migraine pain. Brand name: Treximet Generic name/category: sumatriptan and ...
  2 days ago

• House Bill Wants Pharma To Disclose CME Funding

  
  Pharmalot — Authority: 596
  The health care reform bill passed by the House would force drugmakers to disclose how much they spend on continuing medical education classes for docs, although the Senate version doesn’t include such a requirement, according to The Wall Street Journal . The paper notes this comes as for-profit CME firms ...
  2 days ago

• FTC Eyes Supply Dispute Between Drugmakers

  
  Pharmalot — Authority: 596
  The Federal Trade Commission is concerned that some brand-name drugmakers are declining to supply some bulk ingredients to their generic rivals which, of course, want to use materials to make copies of more expensive meds, The Wall Street Journal writes. Meanwhile, GlaxoSmithKline cites a federal drug-safety ...
  2 days ago

• FDA chief defends H1N1 vaccine supply

  
  Get Out of Dodge! — Authority: 137
  The head of the U.S. Food and Drug Administration defended the agency’s decision not to use an additive that could have stretched swine flu vaccine supplies, adding that doses should be coming more regularly. The vaccine to prevent the H1N1 strain of influenza has been in short supply following production issues ...
  2 days ago

• Ironwood Nabs $75M in Deal With Japanese Firm, Gloucester Drug Gets FDA Approval, Alnylam Branches Into Biomanufacturing Tech, & More Boston-Area Life Sciences News

  
  Xconomy — Authority: 710
  Roundup , Life Sciences , FDA Rebecca Zacks wrote: Several of New England’s life sciences firms had good news to report this week. —Ryan gave a run-down of the key insights to emerge from our Xconomy Forum on pharma innovation . Sirtris CEO Christoph Westphal, for example, offered insight into one of ...
  2 days ago

• Swine flu sales: windfall or hard work?

  
  Summit Notebook — Authority: 499
  Swine flu is turning out to be a sales bonanza for drug companies - just don’t call it a windfall, says GlaxoSmithKline. As one of the world’s top suppliers of both vaccines and antiviral medicine, CEO Andrew Witty resents the implication that billions of dollars of business simply fell into his company’s lap ...
  2 days ago

• Swine flu sales: windfall or hard work?

  
  Global News Blog — Authority: 472
  Swine flu is turning out to be a sales bonanza for drug companies - just dont call it a windfall, says GlaxoSmithKline. As one of the worlds top suppliers of both vaccines and antiviral medicine, CEO Andrew Witty resents the implication that billions of dollars of business simply fell into his companys lap when the ...
  2 days ago

• Stiefel Labs Closing in New York, 260 Jobs Will be Lost

  
  EmploymentSpectator — Authority: 136
  Stiefel Labs, a maker of dermatology and skin-care products, was bought out by GlaxoSmithKline in July of this year. GSK announced on wednesday that it plans to shut down the New York laboratory and move the work from there to other domestic and international locations. The plant employs 260 people who will be out ...
  2 days ago

• Glaxo Gets FDA Approval for H1N1 (Swine) Flu Vaccine

  
  The Medical Quack — Authority: 515
  38 Million of the 250 million doses ordered by the government are available, but Glaxo said it’s approved vaccine won’t ship until next month.  This has been absolutely a fire drill to get supplied out in the US.  In the meantime, Glaxo is continuing to close facilities like some of the other manufacturers ...
  3 days ago

• The day ahead: Thursday

  
  From Reuters.com — Authority: 127
  Wal-Mart sales numbers will hold the spotlight along with results from Walt Disney and Anheuser-Busch InBev. Highlights: *   Wal-Mart is expected to report higher third-quarter earnings, but Wall Street is focused on U.S. sales, which the retailer has stopped reporting on a monthly basis. *  Walt Disney is ...
  3 days ago

• Aileron’s New Class of Drugs Shown to Get Inside Cells to Block Prime Cancer Target

  
  Xconomy — Authority: 710
  Biotech , cancer , Drugs Luke Timmerman wrote: Cambridge, MA-based Aileron Therapeutics has bet the company on the idea that it has discovered a whole new class of drugs that, like RNA interference, can hit targets in the body that are beyond the reach of conventional chemical compounds and biotech ...
  3 days ago

• Swine flu: GlaxoSmithKline will donate 50 million vaccine doses to poor nations

  
  DailyFinance — Authority: 796
  Filed under: Healthcare , GlaxoSmithKline , Novartis The U.S. may worry about having enough H1N1 vaccine to protect its population from swine flu, but at least its getting precious doses. Many developing countries, which cant afford the sometimes expensive medication, dont have any at all. That may change soon. ...
  4 days ago

• Right Brains Wanted: Sanofi-Aventis Wants to Tap the Creative Genius of Boston-Area Biotechs

  
  Xconomy — Authority: 710
  Life Sciences , Drug Development , biotechnology Ryan McBride wrote: Sanofi-Aventis (NYSE: SNY ) hosted a large event at its R&D site in Cambridge, MA, yesterday to make its pitch for why Boston-area biotech companies should want to form partnerships with the French drug giant. It was an ...
  4 days ago

• Pharmalot… Pharmalittle… Morning Edition

  
  Pharmalot — Authority: 596
  Top of the morning, everyone. And a pleasant one, it is. Of course, rousting one of the short people from bed is proving challenging today - those of you with adolescents may understand. Still, we soldier on. And that calls for a cup of stimulation or two. While we brace ourselves, here are a few items to help you ...
  5 days ago

Comments about glaxosmithkline